#DIDI XIMALAYA LINKDOC IPOTIMES PROFESSIONAL#

The officials reportedly said firms that don’t collect sensitive data, such as pharmaceutical companies, will probably be green-lighted by regulators to move forward with public listings abroad, according to the sources.Ĭhina is in the midst of hammering out a set of new mandates that would essentially prohibit firms that collect and store reams of data from filing for U.S. Related: Parade Of Chinese US IPOs Turns Into A Deluge Of Delays The proposed regulations are still undergoing final review and the CSRC anticipates being able to implement the new laws near the fourth quarter, and until then, asked some firms to sit tight, the sources said. and other countries on the back burner, the sources said. The Financial Times reported on Thursday that Keep, a Chinese sports-oriented social platform, and Ximalaya, the largest podcast platform in China, have both cancelled previous IPO plans in the United States during recent weeks.The China Securities Regulatory Commission (CSRC) reportedly asked firms that collect a high volume of sensitive information to put plans for initial public offerings (IPOs) in the U.S. On the same day, Reuters reported that LinkDoc, a Chinese medical technology company, had also shelved its IPO plan. On May 1, Ximalaya submitted an IPO application to the SEC, with Goldman Sachs, Morgan Stanley, Bank of America and CICC acting as joint underwriters. On May 12, LinkDoc was reported to be planning an IPO, cooperating with Bank of America, CICC and Morgan Stanley, possibly raising about $500 million in the process. At the end of the month, IFR reported that Keep, supported by SoftBank and Tencent, also intended to go to the United States for an IPO, raising $500 million. Pandaily previously reported that LinkDoc had originally prepared to list on the Nasdaq on July 9, under ticker symbol “LDOC,” where it planned to issue 10.8 million American Depository Shares (ADS). Each ADS is equivalent to four common shares, with the issue price ranging from $17.5 to $19.5.Īccording to CareerIn, citing people familiar with the matter, in the future overseas listings of Chinese companies, including offshore entities, will increasingly be brought under the supervision of China Securities Regulatory Commission. In July, 2021, Chinese authorities issued a circular calling for the removal of the “Didi Chuxing” app, then carried out network security reviews on “Yunmanman,” “Huochebang” and “BOSS Zhipin” to ensure accordance with the law. The developments have already had a strong impact on other companies preparing to list publicly in the United States. SEE ALSO: Didi’s Mini Programs Removed from WeChat and Alipay, Affecting Its Business Prior to this, on June 11 government officials tested the collection and use of personal information by a range of widely-used apps,notifying 129 of them, including Keep, of their illegal harvesting and use of user data. Keep is a fitness app with various social networking attributes, and has amassed more than 200 million users.

#DIDI XIMALAYA LINKDOC IPOTIMES PROFESSIONAL#

Ximalaya, or Xima FM, is a professional audio sharing platform used widely in China, which provides consumers with best-selling international audio books, English courses taught by world-renowned professors, Chinese courses for industry experts, and more. The platform currently boasts more than 400 million registered users.

Pandaily previously reported that Didi was officially listed on the NYSE on the evening of June 30, under ticker symbol “DIDI”. The ride-hailing firm’s IPO price was set at $14 per share, raising at least $4.4 billion, and closed up 15.98% to reach $16.4 the next day, with a market value of $78.6 billion.

However, less than 48 hours after its listing, Didi was reviewed by Chinese authorities on the grounds of preventing national data security risks and safeguarding public interests.

Just one day later, the government announced that the “Didi Chuxing” app had been removed from digital stores due to alleged illegal collection and use of personal information.HONG KONG - Chinese medical data group LinkDoc Technology has called off its U.S. initial public offering at the last minute, two people familiar with the transaction said, becoming the first casualty of Beijing’s clampdown on overseas listings. The company planned to raise up to $210 million on the tech-heavy Nasdaq exchange and closed its books on the deal on Wednesday after apparent strong demand. However, market volatility, regulatory uncertainty and fear of angering Chinese regulators have prompted the company to cancel the offering, one of the people said.

Didi ximalaya linkdoc ipotimes